Free Trial

Dimensional Fund Advisors LP Lowers Stock Position in DaVita Inc. $DVA

DaVita logo with Medical background

Key Points

  • Dimensional Fund Advisors LP has reduced its stake in DaVita Inc. by 2.8%, now owning 877,318 shares valued at approximately $134 million.
  • Several hedge funds have adjusted their positions in DaVita, with GAMMA Investing LLC significantly increasing its stake by over 14,000% in the first quarter.
  • Analysts have mixed views on DaVita's stock, with Wall Street Zen upgrading it to "buy," while Barclays set a lower price target of $160.
  • Interested in DaVita? Here are five stocks we like better.

Dimensional Fund Advisors LP cut its stake in shares of DaVita Inc. (NYSE:DVA - Free Report) by 2.8% in the first quarter, according to its most recent disclosure with the SEC. The firm owned 877,318 shares of the company's stock after selling 25,100 shares during the period. Dimensional Fund Advisors LP owned about 1.14% of DaVita worth $134,185,000 at the end of the most recent quarter.

A number of other large investors also recently added to or reduced their stakes in the stock. Wealth Enhancement Advisory Services LLC raised its position in DaVita by 2.0% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 3,551 shares of the company's stock worth $531,000 after acquiring an additional 69 shares during the period. UMB Bank n.a. raised its position in DaVita by 65.5% during the first quarter. UMB Bank n.a. now owns 192 shares of the company's stock worth $29,000 after acquiring an additional 76 shares during the period. Exchange Traded Concepts LLC raised its position in DaVita by 8.9% during the first quarter. Exchange Traded Concepts LLC now owns 970 shares of the company's stock worth $148,000 after acquiring an additional 79 shares during the period. Mather Group LLC. raised its position in shares of DaVita by 7.0% in the first quarter. Mather Group LLC. now owns 1,201 shares of the company's stock valued at $184,000 after buying an additional 79 shares during the last quarter. Finally, National Pension Service raised its position in shares of DaVita by 74.3% in the first quarter. National Pension Service now owns 197 shares of the company's stock valued at $30,000 after buying an additional 84 shares during the last quarter. 90.12% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at DaVita

In related news, insider James O. Hearty sold 2,351 shares of the firm's stock in a transaction dated Wednesday, July 23rd. The shares were sold at an average price of $150.00, for a total transaction of $352,650.00. Following the completion of the sale, the insider directly owned 26,038 shares in the company, valued at approximately $3,905,700. This trade represents a 8.28% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 1.50% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently commented on DVA shares. Barclays reduced their target price on shares of DaVita from $169.00 to $160.00 and set an "equal weight" rating for the company in a research report on Thursday, August 7th. Truist Financial set a $148.00 target price on shares of DaVita in a research report on Friday, August 8th. Finally, Wall Street Zen upgraded shares of DaVita from a "hold" rating to a "buy" rating in a research report on Friday, August 22nd. Three analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, DaVita currently has an average rating of "Hold" and a consensus price target of $164.00.

View Our Latest Research Report on DaVita

DaVita Trading Down 0.7%

DaVita stock traded down $0.96 during midday trading on Wednesday, hitting $137.72. 506,657 shares of the stock were exchanged, compared to its average volume of 893,679. DaVita Inc. has a fifty-two week low of $126.07 and a fifty-two week high of $179.60. The stock has a market capitalization of $9.85 billion, a price-to-earnings ratio of 13.54, a PEG ratio of 0.99 and a beta of 1.09. The stock's 50-day simple moving average is $139.70 and its 200 day simple moving average is $143.37. The company has a current ratio of 1.39, a quick ratio of 1.34 and a debt-to-equity ratio of 23.18.

DaVita (NYSE:DVA - Get Free Report) last released its quarterly earnings data on Tuesday, August 5th. The company reported $2.95 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.70 by $0.25. DaVita had a net margin of 6.35% and a return on equity of 369.39%. The firm had revenue of $3.38 billion during the quarter, compared to analysts' expectations of $3.36 billion. During the same period last year, the business earned $2.00 earnings per share. DaVita's revenue was up 6.1% compared to the same quarter last year. DaVita has set its FY 2025 guidance at 10.200-11.300 EPS. On average, equities analysts anticipate that DaVita Inc. will post 10.76 EPS for the current year.

DaVita Company Profile

(Free Report)

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.

Read More

Institutional Ownership by Quarter for DaVita (NYSE:DVA)

Should You Invest $1,000 in DaVita Right Now?

Before you consider DaVita, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DaVita wasn't on the list.

While DaVita currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.